MDMI is focused on making the medicines development process more efficient and less resource intensive by achieving the full potential of medicine development tools (MDTs). The long-term goal of the Initiative is to create a modern approach that brings all stakeholders and the technological and scientific advances of recent decades fully to bear.

Much like the technology industry’s transition to agile, user-facing software development, this modern medicines development ecosystem will include a transparent process to collect comprehensive, detailed needs and expectations from all stakeholders up front, routine interim opportunities to gather stakeholder feedback as the process progresses, and the ability to transparently shift direction as interim feedback is collected – all with the goal of more rapidly and efficiently delivering medicines that are more valuable to more stakeholders.